Phase 1 study of fianlimab, a human lymphocyte activation gene-3 monoclonal antibody, in combination with cemiplimab in advanced melanoma: Expansion cohort analysis

SKIN The Journal of Cutaneous Medicine(2023)

引用 0|浏览24
暂无评分
关键词
advanced melanoma,fianlimab,monoclonal antibody,cemiplimab
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要